SCHEMBL38666373

SCHEMBL38666373

CC(=O)NCc1cccc(N2CCN(C)CC2)c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 3/20 0.56
▸ HTR2C P28335 3/20 0.56
▸ HTR2B P41595 3/20 0.56
▸ AGXT P21549 1/20 0.55
▸ MAPK14 Q16539 1/20 0.53
▸ SIRT6 Q8N6T7 1/20 0.51
▸ PLOD2 O00469 1/20 0.50
▸ PLOD3 O60568 1/20 0.50
▸ PLOD1 Q02809 1/20 0.50
▸ PRMT6 Q96LA8 1/20 0.50
▸ ADRA2C P18825 1/20 0.49
▸ GFER P55789 1/20 0.48
▸ HTR6 P50406 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ AURKA O14965 1/20 0.48
▸ CCNA2 P20248 1/20 0.48
▸ CDK2 P24941 1/20 0.48
▸ CCNA1 P78396 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28156586 0.89 PRMT6 (0.64) HTR2AHTR2CHTR2BAGXTPRMT6
SCHEMBL27113249 0.82 AGXT (0.57) HTR2AAGXTMAPK14SIRT6PLOD2
SCHEMBL20425007 0.78 ITGB3 (0.64) HTR2AHTR2CHTR2BAGXTPLOD2
SCHEMBL5790197 0.78 AGXT (0.61) AGXTMAPK14PLOD2PLOD3PLOD1
SCHEMBL15710135 0.78 AGXT (0.58) HTR2AHTR2CHTR2BAGXTPLOD2
SCHEMBL29589898 0.78 AGXT (0.58) HTR2AHTR2CHTR2BAGXTPLOD2
SCHEMBL11891932 0.77 AGXT (0.65) AGXTPLOD2PLOD3PLOD1PRMT6
SCHEMBL28739636 0.77 ITGB3 (0.62) HTR2AHTR2CHTR2BAGXTPLOD2
SCHEMBL17890851 0.77 AGXT (0.57) HTR2AHTR2CHTR2BAGXTSIRT6
SCHEMBL5790195 0.77 AGXT (0.61) HTR2AHTR2CHTR2BAGXTPLOD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026106389-A1 NMT INHIBITOR AND USE THEREOF 주식회사 이노보테라퓨틱스 2026-05-21 — — WO claimed
WO-2026106389-A1 NMT INHIBITOR AND USE THEREOF 주식회사 이노보테라퓨틱스 2026-05-21 — — WO disclosed
Send feedback